Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Foot Ulcers: early-phase trial registry
A small indexed set (13 trials) with no open enrollment listed right now.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · none currently recruiting · #1,315 of 28,707 conditions by registered trial count
Diabetic Foot Ulcers: 13 US clinical trials tracked, none currently recruiting.
Diabetic Foot Ulcers is the subject of 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is US Department of Veterans Affairs, running 2 of these trials.
Enrollment posture brief
Registry condition diabetic-foot-ulcers
OPEN 0 | RECR 0% | LATE 2 | EARLY 5 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Diabetic Foot Ulcers has no open enrollment in this registry pull (13 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Foot Ulcers on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Foot Ulcers is recruiting below its size-band peers.
0 of 13 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Diabetic Foot Ulcers research.
US Department of Veterans Affairs accounts for 2 of 13 trials (15.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Foot Ulcers enrolment sits around 100 participants.
Median target enrolment is 100 among the 13 trials that report a genuine target (sentinel values excluded). 6 of those (46.2%) plan for fewer than 100 participants.
-
Diabetic Foot Ulcers splits between interventional and observational designs.
9 interventional and 4 observational studies make up this index (69.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
13 total, page 1 of 1
Wound Healing Endpoint and Recurrence
Sashwati Roy
NCT02577120
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Jiangsu ProteLight Pharmaceutical & Biotechnology Co.
NCT06189638
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
US Department of Veterans Affairs
NCT00013286
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
Abeona Therapeutics
NCT00563394
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
US Department of Veterans Affairs
NCT00013299
Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers
HyperMed
NCT00617916
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
University of Texas Southwestern Medical Center
NCT01221207
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
OcuNexus Therapeutics
NCT01490879
UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
University of Texas Southwestern Medical Center
NCT02463500
A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
Healthpoint
NCT01143714
Non-Invasive Assessment of Wound Healing With Optical Methods
Drexel University College of Medicine
NCT00578604
Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy
KCI USA
NCT00847730
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
Xequel Bio
NCT02652754
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Foot Ulcers records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Foot Ulcers trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Foot Ulcers page
13 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Diabetic Foot Ulcers trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- US Department of Veterans Affairs sponsors the most Diabetic Foot Ulcers trials on record, review their full trial history before evaluating a specific study. See US Department of Veterans Affairs's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Foot Ulcers condition card totals 13 registered trials; most-linked intervention Nexagon® vehicle; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.